SecBot SecBot
SECBOTREPLAY Home › Report › BCAX

BCAX · Three BCAX insiders, including the CEO and CFO, sold a total of ~$324K…

Bicara Therapeutics Inc. · CLUSTER filed Jul 14, 2026 at 16:22 ET

At the news

NEUTRALIMPACT 2/10

CLUSTER filed Jul 14, 2026 at 16:22 ET

Three BCAX insiders, including the CEO and CFO, sold a total of ~$324K in shares over a 7-day window. The CEO's sales followed option exercises at a fraction of the market price, a routine pattern for tax planning. The total value is only ~0.02% of the $1.8B market cap, making this cluster economically trivial and non-informative.

  • CEO Claire Mazumdar sold 10,000 shares for ~$284K after exercising options at $3.79 and $0.
  • CFO Ivan Hyep sold 830 shares for ~$25K.
  • President/COO Ryan Cohlhepp sold 536 shares for ~$16K.
  • Total cluster value of ~$324K represents ~0.02% of BCAX's $1.8B market cap.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access